Considering the distribution of tau aggregates differs from each other in these dementias [141], using imaging techniques rather than CSF biochemical biomarkers to visualize the level of tau burden and the spatial distribution seems more anticipated and powerful. This evidence concerns the gene MAPT and dementia.